총 8건

해외임상승인현황 정보 :: 순번, 임상시험 제목, 적응증, 연구설계, 의뢰자/실시기관, 임상단계, 게시일자
순번 임상시험 제목 적응증 연구설계 의뢰자/실시기관 임상단계 게시일자
1 Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma Asthma Biological: Tezepelumab|Other: Placebo AstraZeneca|Amgen Phase 3 2019-01-07
2 An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) Ulcerative Colitis Drug: Mirikizumab|Drug: Placebo Eli Lilly and Company Phase 3 2018-06-18
3 Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study Acute Lymphoblastic Leukemia|Leukemia, Acute Myeloid (AML), Child|Lymphoma, Non-Hodgkin|Myelodysplastic Syndromes|Primary Immunodeficiency|Anemia, Aplastic|Hemoglobinopathies|Cytopenia|Fanconi Anemia|Diamond Blackfan Anemia|Thalassemia|Anemia, Sickle Cell Drug: Rimiducid|Biological: rivogenlecleucel Bellicum Pharmaceuticals Phase 1|Phase 2 2017-01-01
4 An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (棺) Thalassemia Erythrocyte Transfusion|Beta-Thalassemia Drug: Luspatercept|Other: Placebo Celgene Corporation|Acceleron Pharma, Inc. Phase 3 2016-05-01
5 Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer Patients Breast Cancer Drug: Paclitaxel|Drug: Durvalumab King Faisal Specialist Hospital & Research Center|AstraZeneca Phase 1|Phase 2 2016-01-01
6 Study of 1st Line Therapy Study of MEDI4736 With Tremelimumab Versus SoC in Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE). Non Small Cell Lung Carcinoma (NSCLC) Biological: MEDI4736+Tremelimumab|Drug: Paclitaxel + carboplatin|Drug: Gemcitabine + cisplatin|Drug: Gemcitabine + carboplatin|Drug: Pemetrexed + cisplatin|Drug: Pemetrexed + carboplatin AstraZeneca Phase 3 2015-11-01
7 Effects of Abatacept in Patients With Early Rheumatoid Arthritis Rheumatoid Arthritis Drug: Abatacept|Drug: Methotrexate|Other: Abatacept Placebo|Other: Methotrexate Placebo Bristol-Myers Squibb Phase 3 2015-08-01
8 A Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC) Non-Small Cell Lung Cancer Drug: Nivolumab|Drug: Ipilimumab|Drug: Carboplatin|Drug: Cisplatin|Drug: Gemcitabine|Drug: Pemetrexed Bristol-Myers Squibb|Ono Pharmaceutical Co. Ltd Phase 3 2015-08-01